MicroRNAs associated with the pathways involved in the pathogenesis of abdominal aortic aneurysms

Artery Research

Volumn 7, Issue 1, 2013, Pages 28-35

  Stather, P W ^a   Wild, J B ^a   Sylvius, N ^a   Choke, E ^b   Sayers, R D ^b   Bown, M J ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b Leicester Cardiovascular Biomedical Research Unit   (United Kingdom)

Author keywords

Aneurysm; Extracellular matrix; MicroRNA; MiRNA; Vascular smooth muscle cell

Indexed keywords

MATRIX METALLOPROTEINASE; MICRORNA; MICRORNA 146A; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 26A; MICRORNA 29B; MICRORNA19B; PANCREATIC ELASTASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RNA INDUCED SILENCING COMPLEX; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ABDOMINAL AORTA ANEURYSM; CELL DEDIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENOME ANALYSIS; HUMAN; MEDICAL LITERATURE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PUBLICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA PROCESSING; SMOOTH MUSCLE FIBER; SYSTEMATIC REVIEW; THORACIC AORTA ANEURYSM; VASCULAR SMOOTH MUSCLE;

EID: 84874329104     PISSN: 18729312     EISSN: 18764401     Source Type: Journal    
DOI: 10.1016/j.artres.2012.09.005     Document Type: Review

References (69)

1. Thompson R.W., Curci J.A., Ennis T.L., Mao D., Pagano M.B., Pham C.T. Pathophysiology of abdominal aortic aneurysms: insights from the elastase-induced model in mice with different genetic backgrounds. Ann N Y Acad Sci 2006, 1085:59-73.
2. Ailawadi G., Eliason J.L., Upchurch G.R. Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg 2003, 38(3):584-588.
3. Lopez-Candales A., Holmes D.R., Liao S., Scott M.J., Wickline S.A., Thompson R.W. Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol 1997, 150(3):993-1007.
4. Ailawada G., Eliason J.L., Roelofs K.J., Sinha I., Hannawa K.K., Kaldjian E.P., et al. Gender differences in experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol 2004, 24(11):2116-2122.
5. Tili E., Michaille J.J., Calin G.A. Expression and function of micro-RNAs in immune cells during normal or disease state. Int J Med Sci 2008, 5(2):73-79.
6. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementary to lin-14. Cell 1993, 75(5):843-854.
7. Rougvie A.E. Control of developmental timing in animals. Nat Rev Genet 2001, 2(9):690-701.
8. Grosshans H., Slack F.J. Micro-RNAs: small is plentiful. J Cell Biol 2002, 156:17-21.
9. Homo sapiens miRNAs in the miRBase, at Manchester University.
10. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19(1):92-105.
11. Bhatti I., Lee A., Lund J., Larvin M. Small RNA: a large contributor to carcinogenesis?. J Gastrointest Surg 2009, 13:1379-1388.
12. Pratt A., MacRae I. The RNA-induced silencing complex: a versatile gene-silencing machine. J Biol Chem 2009, 284(27):17897-17901.
13. Gregory R.I., Chendrimada T.P., Cooch N., Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005, 123(4):631-640.
14. Okamura K., Chung W.J., Lai E.C. The long and short of inverted repeat genes in animals: microRNAs, mirtrons and hairpin RNAs. Cell Cycle 2008, 7(18):2840-2845.
15. Park J.Y., Helm J., Coppola D., Kim D., Malafa M., Kim S.J. MicroRNAs in pancreatic ductal adenocarcinoma. World J Gastrointerol 2011, 17(7):817-827.
16. Wu W., Sun M., Zou G.M., Chen J. MicroRNA and cancer: current status and prospective. Int J Cancer 2007, 120:953-960.
17. Jiang S., Li C., Olive V., Lykken E., Feng F., Sevilla J., et al. Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. Blood 2011, 118(20):5487-5497.
18. Yang C.H., Yue J., Pfeffer S.R., Handorf C.R., Pfeffer L.M. MicroRNA-21 regulates the metastatic behaviour of B16 melanoma cells. J Biol Chem 2011, 286(45):39172-39178.
19. Tsunoda T., Takashima Y., Yoshida Y., Doi K., Tanaka Y., Fujimoto T., et al. Oncogenic KRAS regulates miR-200c and miR-221/222 in a 3D-specific manner in colorectal cancer cells. Anticancer Res 2011, 31(7):2453-2459.
20. Obernosterer G., Leuschner P.J., Alenius M., Martinez J. Post-transcriptional regulation of microRNA expression. RNA 2006, 12(7):1161-1167.
21. Baskerville S., Bartell D.P. Microarray profiling of microRNA reveals frequent coexpression with neighboring miRNAs and host genes. RNA 2005, 11:241-247.
22. Rodriguez A., Griffiths-Jones S., Ashurst J.L., Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res 2004, 14:1902-1910.
23. Latronico M.V.G., Catalucci D., Condorelli G. Emerging role of microRNAs in cardiovascular biology. Circ Res 2007, 101:1225-1236.
24. Altuvia Y., Landgraf P., Lithwick G., Elefant N., Pfeffer S., Aravin A., et al. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res 2005, 33(8):2697-2706.
25. Maegdefessel L., Azuma J., Toh R., Merk D.R., Deng A., Chin J.T., et al. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest 2012, 122(2):497-506.
26. Boon R.A., Seeger T., Heydt S., Fischer A., Hergenreider E., Horrevoets A.J., et al. MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res 2011, 109(10):1115-1119.
27. Thompson A.R., Drenos F., Hafez H., Humphries S.E. Candidate gene association studies in abdominal aortic aneurysm disease: a review and meta-analysis. Eur J Vasc Endovasc Surg 2008, 35(1):19-30.
28. Maegdefessel L., Azuma J., Toh R., Deng A., Merk D.R., Raiesdana A., et al. MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion. Sci Transl Med 2012, 4(122):122ra22.
29. Liu G., Huang Y., Lu X., Lu M., Huang X., Li W., et al. Identification and characteristics of microRNAs with altered gene expression patterns in a rat model of abdominal aortic aneurysms. Tohoku J Exp Med 2010, 222(3):187-193.
30. Liao M., Zou S., Weng J., Hou L., Yang L., Zhao Z., et al. A microRNA comparison between thoracic aortic dissection and normal thoracic aorta indicates the potential role of microRNAs in contributing to thoracic aortic dissection pathogenesis. J Vasc Surg 2011, 53(5):1341-1349.
31. Sievers HH, Mohamed SA. MicroRNAs as potential biomarkers in aortic disease. Thoracic and Cardiovascular Surgeon. In: Conference: 40th annual meeting of the German Society for Cardiovascular and Thoracic Surgery; 2011.
32. Jones J.A., Stroud R.E., O'Quinn E.C., Black L.E., Barth J.L., Elefteriades J.A., et al. Selective microRNA suppression in human thoracic aneurysms: relationship of miR-29a to aortic size and proteolytic induction. Circ Cardiovasc Genet 2011, 4(6):605-613.
33. Elia L., Quantivalle M., Zhang J., Contu R., Cossu L., Latronico M.V., et al. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 2009, 16(12):1590-1598.
34. Rowe V.L., Stevens S.L., Reddick T.T., Freeman M.B., Donnell R., Carroll R.C., et al. Vascular smooth muscle cell apoptosis in aneurysmal, occlusive and normal human aorta. J Vasc Surg 2000, 31(3):567-576.
35. Davis-Dusenbery B.N., Wu C., Hata A. Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation. Arterioscler Thromb Vasc Biol 2011, 31(11):2370-2377.
36. Harrison S.C., Kalea A.Z., Holmes M.V., Agu O., Humphries S.E. Genomic research to identify novel pathways in the development of abdominal aortic aneurysm. Cardiol Res Pract 2012, 852829.
37. Cooper D.G., King J.A., Earnshaw J.J. Role of medical intervention in slowing the growth of small abdominal aortic aneurysms. Postgrad Med J 2009, 85:688-692.
38. Ji R., Cheng Y., Yue J., Yang J., Liu X., Chen H., et al. MicroRNA expression signature and anti-sense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ Res 2007, 100(11):1579-1588.
39. Krichevsky A.M., Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med 2009, 13:39-53.
40. Davis B.N., Hilyard A.C., Lagna G., Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454:56-61.
41. Cheng Y., Liu X., Yang J., Lin Y., Xu D.Z., Lu Q., et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009, 105(2):158-166.
42. Boettger T., Beetz N., Kostin S., Schneider J., Kruger M., Hein L., et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 2009, 199(9):2634-2647.
43. Chen J., Yin H., Jiang Y., Radhakrishnan S.K., Huang Z.P., Li J., et al. Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arterioscler Thromb Vasc Biol 2011, 31:368-375.
44. Liu X., Cheng Y., Lin Y., Yang J., Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009, 104:476-487.
45. Davis B.N., Hilyard A.C., Nguyen P.H., Lagna G., Hata A. Induction of microRNA-221 by platelet-derived growth factor signalling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 2009, 284:3728-3738.
46. Sun S.G., Zheng B., Han M., Fang X.M., Li H.X., Miao S.B., et al. miR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep 2011, 12:56-62.
47. Leeper N.R., Raiesdana A., Kojima Y., Chun H.J., Azuma J., Maedefessel L., et al. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 2011, 226:1035-1043.
48. Liu X., Cheng Y., Chen X., Yang J., Xu L., Zhang C. MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2. J Biol Chem 2011, 286(49):42371-42380.
49. Zhang Y., Wang Y., Wang X., Zhang Y., Eisner G.M., Asico L.D., et al. Insulin promotes vascular smooth muscle cell proliferation via microRNA-208-mediated downregulation of p21. J Hypertens 2011, 29(8):1560-1568.
50. Kadoglou N.P., Liapis C.D. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. Curr Med Res Opin 2004, 20(4):419-432.
51. Villarreal G., Oh D.J., Kang M.H., Rhee D.J. Coordinated regulation of extracellular matrix synthesis by the microRNA-29 family in the trabecular meshwork. Invest Ophthalmol Vis Sci 2011, 52(6):3391-3397.
52. Kwiecinski M., Noetel A., Elfimova N., Trebicka J., Schievnbusch S., Strack I., et al. Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction. PLoS One 2011, 6(9):e24568.
53. Luna C., Li G., Qiu J., Epstein D.L., Gonzalez P. Role of miR-29b on the regulation of the extracellular matrix in human trabecular meshwork cells under chronic oxidative stress. Mol Vis 2009, 15:2488-2497.
54. Ott C.E., Grunhagen J., Jager M., Horbelt D., Schwill S., Kallenbach K., et al. MicroRNAs differentially expressed in postnatal aortic development downregulate elastin via 3' UTR coding-sequence binding sites. PLoS One 2011, 6(1):e16250.
55. Fang J.H., Zhou H.C., Zeng C., Yang J., Liu Y., Huang X., et al. MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology 2011, 54(5):1729-1740.
56. Hinterseher I., Bergert H., Kulisch E., Bloomenthal A., Pilarsky Ch, Ockert D., et al. Matrix metalloproteinase 2 polymorphisms in a caucasian population with abdominal aortic aneurysm. J Surg Res 2006, 133(2):121-128.
57. Mott J.L., Kobayashi S., Bronk S.F., Gores G.J. Mir-29 regulates mcl-1 protein expression and apoptosis. Oncogene 2007, 26:6133-6140.
58. Park S.Y., Lee J.H., Ha M., Nam J.W., Kim V.N. Mir-29 miRNAs activate p53 by targeting p85α and cdc42. Nat Struct Mol Biol 2009, 16:23-29.
59. Chen K.C., Wang Y.S., Hu C.Y., Chang W.C., Liao Y.C., Dai C.Y., et al. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J 2011, 25(5):1718-1728.
60. Jones J.A., Beck C., Barbour J.R., Zavadzkas J.A., Mukherjee R., Spinale F.G., et al. Alterations in aortic cellular constituents during thoracic aortic aneurysm development. Am J Pathol 2009, 175:1746-1756.
61. Wu D.G., Wang Y.Y., Fan L.G., Luo H., Han B., Sun L.H., et al. MicroRNA-7 regulates glioblastoma cell invasion via targeting focal adhesion kinase expression. Chin Med J (Engl) 2011, 124(176):2616-2621.
62. Van Almen G.C., Verhesen W., can Leeuwen R.E., van de Vrie M., Eurlings C., Schellings M.W., et al. MicroRNA-18 and microRNA-19 regulated CTGF and TSP-1 expression in age-related heart failure. Aging Cell 2011, 10(5):769-779.
63. Duisters R.F., Tijsen A.J., Schroen B., Leenders J.J., Lentink V., van der Made I., et al. MiR-133 and miR-30 regulate connective tissue growth factor: implication for a role of microRNAs in myocardial matrix remodelling. Circ Res 2009, 104(2):170-178.
64. Helgadottir A., Thorleifsson G., Magnusson K.P., Gretarsdottir S., Steinthorsdottir V., Manolescu A. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008, 40(2):217-224.
65. Gretarsdottir S., Baas A.F., Thorleifsson G., Holm H., den Heijer M., de Vries J.P. Genome-wide association study identifies a variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet 2010, 42(8):692-697.
66. Bown M.J., Jones G.T., Harrison S.C., Wright B.J., Bumpstead S., Baas A.F., et al. Abdominal aortic aneurysm is associated with as variant in low-density lipoprotein receptor-related protein 1. Am J Hum Genet 2011, 89(5):619-627.
67. http://www.ma.uni-heidelberg.de/apps/zmf/mirwalk/.
68. http://mirtarbase.mbc.nctu.edu.tw/.
69. http://mirecords.biolead.org/.